- Report
- December 2023
- 198 Pages
Global
From €4836EUR$4,950USD£4,038GBP
- Report
- October 2024
- 195 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 189 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- June 2024
- 132 Pages
Global
From €4543EUR$4,650USD£3,793GBP
- Report
- June 2024
- 99 Pages
Global
From €4543EUR$4,650USD£3,793GBP
- Report
- June 2024
- 136 Pages
Global
From €4543EUR$4,650USD£3,793GBP
- Report
- December 2023
- 192 Pages
Global
From €4543EUR$4,650USD£3,793GBP
- Report
- November 2024
- 281 Pages
Global
From €5471EUR$5,600USD£4,568GBP
- Report
- July 2024
- 205 Pages
Global
From €2394EUR$2,450USD£1,998GBP
- Report
- April 2024
- 136 Pages
Global
From €2198EUR$2,250USD£1,835GBP
- Report
- March 2024
- 181 Pages
Global
From €2394EUR$2,450USD£1,998GBP
- Report
- January 2024
- 143 Pages
Global
From €2198EUR$2,250USD£1,835GBP
- Report
- December 2023
- 166 Pages
Global
From €2296EUR$2,350USD£1,917GBP
- Report
- November 2023
- 142 Pages
Global
From €2198EUR$2,250USD£1,835GBP
- Report
- November 2023
- 100 Pages
Global
From €5813EUR$5,950USD£4,853GBP
- Report
- October 2024
- 198 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 181 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 196 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 198 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 191 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more